StockData

AVITA Medical vs Sanara MedTech

RCEL and SMTI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RCEL and SMTI compare

AVITA Medical is the larger company, worth 1.6 times as much as Sanara MedTech ($488M against $301M).

Sanara MedTech grew revenue faster over the last twelve months (13.0% versus 1.00% for AVITA Medical).

Sanara MedTech keeps more of each dollar of sales as profit, with a net margin of −29.2% compared with −57.0% at AVITA Medical.

Sanara MedTech scores higher on the StockData Score (6 against 3 for AVITA Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRCELSMTI
Size and price
Market cap$488M$301M
Share price$15.77$32.73
Change, 1 year321%51.9%
Change, 5 years11.8%14.2%
Beta (5Y)1.951.43
Employees226108
StockData Score
Total score36 (better)
Valuation score00
Growth score23 (better)
Performance score11
Health score02 (better)
Dividend score00
Valuation
P/S6.4×2.7× (better)
P/B–37.9×
EV/EBITDA–30.4×
P/FCF–66.8×
FCF yield−5.0%1.5% (better)
Fair value–$13.42
Margin of safety–−144%
Growth
Revenue growth (TTM)1.00%13.0% (better)
Revenue growth, 5Y average67.2% (better)45.9%
Profitability
Gross margin81.6%93.0% (better)
Operating margin−46.6%7.7% (better)
Net margin−57.0%−29.2% (better)
FCF margin−32.5%4.1% (better)
Return on equity–−148%
Return on invested capital−261%13.1% (better)
Financial health
Debt / equity–5.85
Net debt / EBITDA–2.85
Interest coverage−6.5×1.2× (better)
Current ratio0.412.58 (better)
Altman Z-score−10.503.76 (better)
Piotroski F-score33
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions15.9%19.4%
Held by insiders2.7%14.9%
Insider net buying, 12 months$235K–
Short interest, % of float–5.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.